NCT04074564 2023-10-23
MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma
HRYZ Biotech Co.
Phase EARLY_PHASE1 Unknown
Clinical Trials
9 trialsNCT04012827 2022-09-07
Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT04447274 2020-06-25
A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS
ChineseAMS
Phase 2 Unknown
NCT04239443 2020-01-27
Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer
Hunan Cancer Hospital
Phase 2 Unknown
NCT04126811 2019-10-15
Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT04126993 2019-10-15
Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT03539172 2018-05-30
RASS
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Unknown
NCT03121846 2017-05-22
Mesylate Apatinib for Stage â…£ STS After Failure of Chemotherapy
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT03064243 2017-02-27
A Phase II Study of Apatinib in STS Patients
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Phase 2 Unknown